Analyst Ranking
Bottom 13%
#4380 out of 4986 analysts
Average Return
-1.77%
Win Rate
33%19 out of 58
Risk vs Reward
Poor
Good

Elliot Wilbur's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Adma Biologics IncADMA
+270.30%$4.31$15.96
2023-08-10 -
2024-08-09
Strong Buy
Sol Gel Technologies LtdSLGL
+242.70%$4.70$16.10
2024-08-19 -
2025-08-18
Buy
Petiq IncPETQ
+144.62%$7.80$19.08
2022-10-25 -
2023-10-24
Buy
Adma Biologics IncADMA
+126.79%$8.81$19.98
2024-05-10 -
2025-05-09
Strong Buy
Adma Biologics IncADMA
+102.22%$1.35$2.73
2021-10-26 -
2022-10-25
Buy

Elliot Wilbur Analyst Color

Get additional color on Elliot Wilbur's coverage of popular stocks

Elliot Wilbur's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Adma Biologics IncADMA
7Strong Buy$32.00+83.49%Maintains
3 months ago
Ani Pharmaceuticals IncANIP
6Buy$83.00-7.90%Maintains
a year ago
Sol Gel Technologies LtdSLGL
8Buy$40.00N/ADowngrades
a year ago
Organon & CoOGN
1Buy$33.00N/AInitiates Coverage On
2 years ago
Perrigo Co PLCPRGO
5Buy$43.00N/AMaintains
2 years ago
Petiq IncPETQ
4Buy$16.00N/AMaintains
3 years ago
Polypid LtdPYPD
3Buy$120.00N/ADowngrades
3 years ago
Covetrus IncCVET
4HoldN/AN/ADowngrades
3 years ago
Plx Pharma IncPLXPQ
3Buy$10.00N/AMaintains
3 years ago
Antares Pharma IncATRS
4HoldN/AN/ADowngrades
3 years ago
Viatris IncVTRS
3HoldN/AN/ADowngrades
3 years ago
Teva Pharmaceutical Industries LtdTEVA
2HoldN/AN/ADowngrades
4 years ago
Flexion Therapeutics IncFLXN1
4HoldN/AN/ADowngrades
4 years ago
Zoetis IncZTS
4HoldN/AN/ADowngrades
4 years ago
Elanco Animal Health IncELAN
1HoldN/AN/AInitiates Coverage On
6 years ago
Dermira IncDERM2
2HoldN/AN/AUpgrades
7 years ago
Allergan PLCAGN
2Buy$198.00N/AMaintains
7 years ago
Amphastar Pharmaceuticals IncAMPH
2HoldN/AN/ADowngrades
8 years ago
Dmk Pharmaceuticals CorpDMKPQ
1Buy$490.00N/AInitiates Coverage On
8 years ago
Aerie Pharmaceuticals IncAERI
1HoldN/AN/ADowngrades
8 years ago
Lannett Co IncLCINQ
2Buy$172.00N/AMaintains
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.